Skip to main content

    Cumberland Pharmaceuticals Inc repurchased $257,819 of its common stock in fiscal Q3 2026

    GNG Research Market News

    By GNG Research

    Cumberland Pharmaceuticals Inc (CPIX) repurchased $257,819.00 of its common stock in fiscal Q3 2026.

    Accepted November 13, 2026.

    Repurchases in fiscal Q3 2025 were $10,439.00.

    The quarter amount is the difference between the filed year-to-date amounts.